| Authors: |
Kostadinova KA; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK., Venne JL; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK., Krajcovicova S; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.; Department of Organic Chemistry, Faculty of Science, Palacky University Olomouc, Olomouc, Czech Republic., Dodgson J; Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, UK., Hogendorf WFJ; Therapeutics Discovery, Novo Nordisk A/S, Måløv, Denmark., Nielsen TE; Therapeutics Discovery, Novo Nordisk A/S, Måløv, Denmark., Hymel D; Novo Nordisk US R&D, Lexington, Massachusetts, USA., Bolt H; Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, UK.; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Collinson A; Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, UK., Day J; Department of Earth Sciences, University of Cambridge, Cambridge, UK., Revell J; Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, UK.; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Spring DR; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK. |
